Year |
Citation |
Score |
2023 |
Gits HC, Khosravi Flanigan MA, Kapplinger JD, Reisenauer JS, Eiken PW, Breen WG, Vu LH, Welch BT, Harmsen WS, Day CN, Olivier KR, Park SS, Garces YI, Hallemeier CL, Merrell KW, et al. Sub-Lobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy. Chest. PMID 38103730 DOI: 10.1016/j.chest.2023.12.013 |
0.341 |
|
2022 |
Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, et al. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clinical Lung Cancer. PMID 36104272 DOI: 10.1016/j.cllc.2022.07.017 |
0.341 |
|
2020 |
Deek MP, Taparra K, Dao D, Chan L, Phillips R, Gao RW, Kwon ED, Deville C, Song DY, Greco S, Carducci MA, Eisenberger M, DeWeese TL, Denmeade S, Pienta K, ... ... Olivier KR, et al. Patterns of Recurrence and Modes of Progression Following Metastasis Directed Therapy in Oligometastatic Castration Sensitive Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 32798608 DOI: 10.1016/J.Ijrobp.2020.08.030 |
0.35 |
|
2020 |
Deek MP, Taparra K, Phillips R, Velho PI, Gao RW, Deville C, Song DY, Greco S, Carducci M, Eisenberger M, DeWeese TL, Denmeade S, Pienta K, Paller CJ, Antonarakis ES, ... Olivier KR, et al. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer. European Urology Oncology. PMID 32536574 DOI: 10.1016/J.Euo.2020.05.004 |
0.377 |
|
2020 |
Breen WG, Garces YI, Olivier KR, Park SS, Merrell KW, Nichols FC, Peikert TD, Molina JR, Mansfield AS, Roden AC, Blackmon SH, Wigle DA. Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience. Frontiers in Oncology. 10: 392. PMID 32266156 DOI: 10.3389/Fonc.2020.00392 |
0.423 |
|
2020 |
Jethwa KR, Jang S, Mullikin TC, Harmsen WS, Petersen MM, Olivier KR, Park SS, Neben-Wittich MA, Hubbard JM, Sandhyavenu H, Whitaker TJ, Waltman LA, Kipp BR, Merrell KW, Haddock MG, et al. Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 146: 29-36. PMID 32114263 DOI: 10.1016/J.Radonc.2020.02.008 |
0.392 |
|
2020 |
Jimenez RB, Johnson A, Padilla L, Yechieli R, Forman R, Horick N, Thomas H, Gunther JR, Olivier K, Golden DW, Fields E. The Impact of an Introductory Radiation Oncology Curriculum (IROC) for Radiation Oncology Trainees Across the US and Canada. International Journal of Radiation Oncology, Biology, Physics. PMID 32057993 DOI: 10.1016/J.Ijrobp.2020.02.015 |
0.338 |
|
2020 |
Stewart G, Breen W, Stish BJ, Park SS, Olivier KR, Costello BA. Thoracic radiotherapy for renal cell carcinoma metastases. Journal of Clinical Oncology. 38: 409-409. DOI: 10.1200/Jco.2020.38.6_Suppl.409 |
0.316 |
|
2019 |
Kazemi NY, Jain C, Bois MC, Behfar A, Olivier K, Markovic SN. Heart Block Caused by Cardiac Metastasis From Merkel Cell Carcinoma: A Case Report. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 3: 510-516. PMID 31993571 DOI: 10.1016/J.Mayocpiqo.2019.09.005 |
0.483 |
|
2019 |
Jethwa KR, Hellekson CD, Evans JD, Harmsen WS, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier KR, Haloi R, Lowe VJ, Welch BT, Quevedo JF, Mynderse LA, et al. C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities. Advances in Radiation Oncology. 4: 659-667. PMID 31673659 DOI: 10.1016/J.Adro.2019.06.006 |
0.409 |
|
2019 |
Burmeister J, Buatti J, Jimenez R, Marcrom S, Olivier K, Price M, Wallner P. Exam Preparation and Performance Reporting Changes for the American Board of Radiology Radiation Oncology Physics Examination: Results From the ASTRO Workgroup. International Journal of Radiation Oncology, Biology, Physics. PMID 31648870 DOI: 10.1016/J.Ijrobp.2019.05.041 |
0.304 |
|
2019 |
Arnett ALH, Mou B, Owen D, Park SS, Nelson K, Hallemeier CL, Sio T, Garces YI, Olivier KR, Merrell KW. Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC. Advances in Radiation Oncology. 4: 422-428. PMID 31011688 DOI: 10.1016/J.Adro.2019.01.002 |
0.449 |
|
2019 |
Gao RW, Olivier KR, Park SS, Davis BJ, Pisansky TM, Choo R, Kwon ED, Karnes RJ, Harmsen WS, Stish BJ. Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases. Advances in Radiation Oncology. 4: 314-322. PMID 31011676 DOI: 10.1016/J.Adro.2019.02.002 |
0.444 |
|
2019 |
Yu NY, Breen W, DeWees TA, Ding JX, Golafshar M, Liu C, Olivier K, Daniels TB, Garces Y, Ross HJ, Park SS, Beamer SE, Paripati HR, Liu W, Schild SE, et al. Long-term Report of Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Radiotherapy (IMRT) for 163 Patients with Stage III Non-small Cell Lung Cancer: A Single-Institution, Two-Campus Experience International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2456 |
0.394 |
|
2019 |
Wilhite TJ, Jethwa KR, Hellekson C, Routman DM, Stish BJ, Petersen M, Harmsen WS, Quevedo FJ, Park SS, Olivier K, Choo CR, Pisansky TM, Mynderse LA, Karnes RJ, Kwon ED, et al. Low Rates of in-Field Recurrence with Regional Nodal Salvage Radiation and Temporary Androgen Deprivation for Pelvic and/or Para-Aortic Prostate Cancer Nodal Recurrences Detected By C11 Choline PET/CT Following Primary Therapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1784 |
0.382 |
|
2019 |
Yu NY, DeWees TA, Breen W, Liu C, Ding JX, Bhangoo RS, Golafshar M, Chiang JS, Olivier K, Daniels TB, Garces Y, Ross HJ, Park SS, Beamer SE, Paripati HR, et al. Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiotherapy (IMRT) for Patients with Stage III Non-Small Cell Lung Cancer: First Comparative Results of Patient-Reported Outcomes (PRO) International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1208 |
0.415 |
|
2018 |
Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, et al. Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30513377 DOI: 10.1016/J.Ijrobp.2018.11.051 |
0.427 |
|
2018 |
Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, et al. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2: 40-48. PMID 30225431 DOI: 10.1016/J.Mayocpiqo.2017.11.001 |
0.38 |
|
2018 |
Evans JD, Morris LK, Zhang H, Cao S, Liu X, Mara KC, Stish BJ, Davis BJ, Mansfield AS, Dronca RS, Iott Cnp MJ, Kwon ED, Foote RL, Olivier KR, Dong H, et al. Prospective Immunophenotyping of CD8 T-cells and Associated Clinical Outcomes of Patients with Oligometastatic Prostate Cancer Treated with Metastasis-Directed SBRT. International Journal of Radiation Oncology, Biology, Physics. PMID 30205124 DOI: 10.1016/J.Ijrobp.2018.09.001 |
0.375 |
|
2018 |
Shiraishi S, Fong de Los Santos LE, Antolak JA, Olivier KR, Garces YI, Park SS, Grams MP. Phantom verification of AAA and Acuros dose calculations for lung cancer: Do tumor size and regression matter? Practical Radiation Oncology. PMID 30138746 DOI: 10.1016/J.Prro.2018.06.008 |
0.36 |
|
2018 |
Ravishankar A, Park SS, Olivier KR, Corbin KS. Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature. Case Reports in Oncology. 11: 168-178. PMID 29681817 DOI: 10.1159/000487478 |
0.375 |
|
2018 |
Jethwa K, Jang S, Olivier K, Park S, Merrell K, Martenson J, Neben-Wittich M, Roberts K, Arnett A, Hubbard J, Whitaker T, Harmsen W, Waltman L, Kipp B, Grothey A, et al. Metastasis-Directed Stereotactic Body Radiation Therapy for Oligometastatic Colorectal Cancer: A Single Institution Experience International Journal of Radiation Oncology*Biology*Physics. 102: e7-e8. DOI: 10.1016/J.Ijrobp.2018.07.209 |
0.395 |
|
2018 |
Laack NN, Whitaker TJ, Harmsen WS, Amundson A, Haddock MG, Ma DJ, Vargas CE, Choo CR, Brown PD, Garces Y, Mutter RW, Petersen IA, Olivier K, Corbin KS, Anderson J, et al. Patient-reported Quality of Life during Photon and Proton Radiation Therapy: Results of a Prospective Registry of Patient Reported Outcomes in a Large-Volume, Multi-Site Practice International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1977 |
0.368 |
|
2018 |
Evans JD, Morris LK, Dong H, Cao S, Liu X, Mara K, Stish BJ, Davis BJ, Olivier K, Mansfield AS, Dronca RS, Iott MJ, Kwon ED, Foote RL, Park SS. Prospective Immunophenotyping of CD8+ T-cells and Associated Clinical Outcomes of Patients with Oligometastatic Prostate Cancer Treated with Metastasis-Directed Stereotactic Body Radiation Therapy International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.06.351 |
0.412 |
|
2018 |
Gao RW, Olivier K, Park SS, Davis BJ, Choo CR, Pisansky TM, Karnes RJ, Kwon ED, Stish BJ. Stereotactic Body Versus Hypofractionated Radiation Therapy for Local Control of Prostate Cancer Bone Metastases International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.06.274 |
0.395 |
|
2017 |
Youland RS, Blanchard ML, Dronca R, Kottschade L, Markovic SN, Olivier KR, Park SS. Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era. Clinical and Translational Radiation Oncology. 6: 25-30. PMID 29594220 DOI: 10.1016/J.Ctro.2017.09.002 |
0.51 |
|
2017 |
Youland RS, Packard AT, Blanchard MJ, Arnett AL, Wiseman GA, Kottschade LA, Dronca RS, Markovic SN, Olivier KR, Park SS. 18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma. Advances in Radiation Oncology. 2: 204-210. PMID 28740933 DOI: 10.1016/J.Adro.2017.02.003 |
0.538 |
|
2017 |
Breen WG, Merrell KW, Mansfield AS, Wigle DA, Garces YI, Park SS, Olivier KR, Hallemeier CL. Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer. Advances in Radiation Oncology. 2: 12-18. PMID 28740911 DOI: 10.1016/J.Adro.2016.12.004 |
0.415 |
|
2017 |
Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery. Practical Radiation Oncology. PMID 28733185 DOI: 10.1016/J.Prro.2017.04.013 |
0.315 |
|
2017 |
Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. International Journal of Radiation Oncology, Biology, Physics. 97: 526-535. PMID 28126302 DOI: 10.1016/J.Ijrobp.2016.11.014 |
0.38 |
|
2017 |
Jethwa K, Davis B, Hellekson C, Evans J, Whitaker T, Wilhite T, Park S, Choo C, Stish B, Olivier K, Lowe V, Johnson G, Mynderse L, Welch T, Quevedo F, et al. 11C-choline PET-guided salvage intensity modulated radiotherapy with simultaneous integrated boost for isolated pelvic and para-aortic prostate cancer nodal recurrences: Minimal adverse effects European Urology Supplements. 16. DOI: 10.1016/S1569-9056(17)31761-X |
0.322 |
|
2017 |
Videtic G, Paulus R, Singh A, Chang J, Parker W, Olivier K, Timmerman R, Komaki R, Urbanic J, Stephans K, Yom S, Robinson C, Belani C, Iyengar P, Ajlouni M, et al. MA 13.08 Long Term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a Randomized Phase II Study of 2 SBRT Schedules for Lung Cancer Journal of Thoracic Oncology. 12: S1853-S1854. DOI: 10.1016/J.Jtho.2017.09.566 |
0.301 |
|
2017 |
Arnett ALH, Packard A, Mara K, Mansfield A, Wigle D, Haddock MG, Park SS, Garces Y, Olivier K, Merrell KW. Poster ViewingFDG-PET Parameters as Predictors of Pathologic Response and Nodal Clearance in Patients with Stage III Non–small Cell Lung Cancer Receiving Neoadjuvant Chemoradiation and Surgery International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1650 |
0.347 |
|
2017 |
Jethwa KR, Davis BJ, Hellekson CD, Evans JD, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier K, Haloi R, Lowe VJ, Mynderse LA, Welch TJ, Quevedo FJ, et al. 11 C-Choline PET-Guided Salvage Radiation Therapy for Isolated Pelvic and Para-aortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Low Rates of Adverse Effects International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1183 |
0.383 |
|
2016 |
Owen D, Mayo CS, Song L, Ahmed K, Laack N, Olivier K. Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy. Advances in Radiation Oncology. 1: 76-81. PMID 28799577 DOI: 10.1016/J.Adro.2015.12.001 |
0.386 |
|
2016 |
Merrell KW, Mou B, Hallemeier CL, Owen DA, Nelson K, Garces YI, Olivier KR. P1.18: Long-Term Clinical Outcomes and Safety Profile for Central Lung SBRT for NSCLC: Track: Early Stage NSCLC (Stage I - III). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S192. PMID 27676504 DOI: 10.1016/J.Jtho.2016.08.040 |
0.301 |
|
2016 |
Parker WP, Davis BJ, Park SS, Olivier K, Choo CR, Nathan MA, Lowe VJ, Welch TJ, Zaid HB, Sobol II, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes JR, et al. Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management. International Journal of Radiation Oncology, Biology, Physics. 96: S112. PMID 27675554 DOI: 10.1016/J.Ijrobp.2016.06.276 |
0.376 |
|
2016 |
Evans JD, Davis BJ, Stish BJ, Park SS, Olivier K, Choo CR, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ. Recurrence Patterns of Oligometastatic Disease Detected Using C-11 Choline Positron Emission Tomography/Computed Tomography in Patients With a Rising Prostate-Specific Antigen Level Following Postprostatectomy Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S103. PMID 27675532 DOI: 10.1016/J.Ijrobp.2016.06.255 |
0.365 |
|
2016 |
Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moriera DM, Haloi R, Tollefson MK, et al. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. European Urology. PMID 27597240 DOI: 10.1016/J.Eururo.2016.08.055 |
0.375 |
|
2016 |
Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdominal Radiology (New York). PMID 27167232 DOI: 10.1007/S00261-016-0768-X |
0.388 |
|
2016 |
Muldermans JL, Romak LB, Kwon ED, Park SS, Olivier KR. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics. 95: 696-702. PMID 27131082 DOI: 10.1016/J.Ijrobp.2016.01.032 |
0.422 |
|
2016 |
Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H. Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927). International Journal of Radiation Oncology, Biology, Physics. 94: 638. PMID 26867895 DOI: 10.1016/J.Ijrobp.2015.11.031 |
0.43 |
|
2016 |
Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Park SS, Ma DJ, ... Olivier KR, et al. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Practical Radiation Oncology. PMID 26825250 DOI: 10.1016/J.Prro.2015.11.001 |
0.302 |
|
2016 |
Kirpotin DB, Tipparaju S, Huang ZR, Kamoun WS, Pien C, Kornaga T, Oyama S, Olivier K, Marks JD, Koshkaryev A, Schihl SS, Fetterly G, Schoeberl B, Noble C, Hayes M, et al. Abstract 3912: MM-310, a novel EphA2-targeted docetaxel nanoliposome Cancer Research. 76: 3912-3912. DOI: 10.1158/1538-7445.Am2016-3912 |
0.362 |
|
2015 |
Grams MP, Fong de Los Santos LE, Antolak JA, Brinkmann DH, Clarke MJ, Park SS, Olivier KR, Whitaker TJ. Cadaveric verification of the Eclipse AAA algorithm for spine SBRT treatments with titanium hardware. Practical Radiation Oncology. PMID 26723553 DOI: 10.1016/J.Prro.2015.10.012 |
0.345 |
|
2015 |
Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). International Journal of Radiation Oncology, Biology, Physics. 93: 757-64. PMID 26530743 DOI: 10.1016/J.Ijrobp.2015.07.2260 |
0.405 |
|
2015 |
Blanchard M, Shim KG, Grams MP, Rajani K, Diaz RM, Furutani KM, Thompson J, Olivier KR, Park SS, Markovic SN, Pandha H, Melcher A, Harrington K, Zaidi S, Vile R. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. International Journal of Radiation Oncology, Biology, Physics. 93: 577-87. PMID 26461000 DOI: 10.1016/J.Ijrobp.2015.07.2274 |
0.57 |
|
2015 |
Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. In Reply to Yartsev and Chen. Practical Radiation Oncology. 5: e555. PMID 26362711 DOI: 10.1016/J.Prro.2015.02.004 |
0.422 |
|
2015 |
Spiceland CM, Olivier KR, Jatoi A. Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer. Journal of Palliative Medicine. 18: 707-10. PMID 26218580 DOI: 10.1089/Jpm.2015.0097 |
0.434 |
|
2015 |
Ost P, Jereczek-Fossa BA, As NV, Zilli T, Muacevic A, Olivier K, Henderson D, Casamassima F, Orecchia R, Surgo A, Brown L, Tree A, Miralbell R, De Meerleer G. Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. European Urology. PMID 26189689 DOI: 10.1016/J.Eururo.2015.07.004 |
0.427 |
|
2015 |
Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiation Oncology (London, England). 10: 43. PMID 25889747 DOI: 10.1186/S13014-015-0340-9 |
0.387 |
|
2015 |
Stish BJ, Hallemeier CL, Olivier KR, Harmsen WS, Allen MS, Garces YI. Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer. Clinical Lung Cancer. PMID 25823413 DOI: 10.1016/J.Cllc.2015.02.004 |
0.369 |
|
2015 |
Ost P, Jereczek-Fossa B, As NV, Zili T, Muacevic A, Brown L, Casamassima F, Orecchia R, Henderson D, Olivier K, Surgo A, Tree A, Meerleer GD. 447 A multi-institutional analysis of stereotactic body radiotherapy for oligometastatic prostate cancer recurrence European Urology Supplements. 14. DOI: 10.1016/S1569-9056(15)60440-7 |
0.339 |
|
2015 |
Hobbs CJ, Ko S, Paryani NN, Olivier K, Garces Y, Park SS, Hallemeier CL, Schild SE, Vora S, Ashman J, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic Body Radiation Therapy (SBRT) for Early-Stage Non-Small Cell Lung Cancer (NSCLC) and Impact of Maximum Standardized Uptake Value (SUVmax), Biologically Effective Dose (BED), and Mediastinal Staging on Prognosis International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.245 |
0.426 |
|
2015 |
Youland R, Blanchard M, Markovic S, Olivier K, Park S. A Comparison of Stereotactic Body Radiation Therapy (SBRT) Versus Conventional/Hypofractionated Radiation Therapy (CHRT) for Metastatic Malignant Melanoma (MM) International Journal of Radiation Oncology*Biology*Physics. 93: E629-E630. DOI: 10.1016/J.Ijrobp.2015.07.2154 |
0.575 |
|
2014 |
Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Frontiers in Oncology. 4: 376. PMID 25642416 DOI: 10.3389/Fonc.2014.00376 |
0.452 |
|
2014 |
Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, Rose PS, Laack NN. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014: 418270. PMID 25548538 DOI: 10.1155/2014/418270 |
0.372 |
|
2014 |
Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. Separating the dosimetric consequences of changing tumor anatomy from positional uncertainty for conventionally fractionated lung cancer patients. Practical Radiation Oncology. 4: 455-65. PMID 25407869 DOI: 10.1016/J.Prro.2014.02.006 |
0.416 |
|
2014 |
Sio TT, Jensen AR, Miller RC, Fong de los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 15: 4931. PMID 25207580 DOI: 10.1120/Jacmp.V15I5.4931 |
0.408 |
|
2014 |
Saito AI, Olivier KR, Li JG, Liu C, Newlin HE, Schmalfuss I, Kyogoku S, Dempsey JF. Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 15: 4434. PMID 24892328 DOI: 10.1120/Jacmp.V15I3.4434 |
0.365 |
|
2014 |
Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Practical Radiation Oncology. 4: e143-9. PMID 24890360 DOI: 10.1016/J.Prro.2013.05.006 |
0.453 |
|
2014 |
Mou B, Beltran CJ, Park SS, Olivier KR, Furutani KM. Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study. Plos One. 9: e98621. PMID 24887068 DOI: 10.1371/Journal.Pone.0098621 |
0.35 |
|
2014 |
Frechette KM, Brown LC, Aubry MC, Wigle DA, Olivier KR. Pseudoprogression after stereotactic body radiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: e29-30. PMID 24736086 DOI: 10.1097/Jto.0000000000000067 |
0.433 |
|
2014 |
Grams MP, Brown LC, Brinkmann DH, Pafundi DH, Mundy DW, Garces YI, Park SS, Olivier KR, de los Santos LE. Analysis of automatic match results for cone-beam computed tomography localization of conventionally fractionated lung tumors. Practical Radiation Oncology. 4: 35-42. PMID 24621421 DOI: 10.1016/J.Prro.2013.02.008 |
0.363 |
|
2014 |
Dong H, Zhao W, Krco CJ, Markovic S, Mansfield AS, Olivier KR, Park SS, Kwon ED. A novel method for identifying downstream signals in tumor-reactive T cells following PD-1 engagement and monitoring endogenous tumor immunity and immunotherapy. Journal of Clinical Oncology. 32: 3049-3049. DOI: 10.1200/Jco.2014.32.15_Suppl.3049 |
0.456 |
|
2014 |
Mou B, Merrell KW, Owen DA, Nelson K, Garces YI, Olivier KR. OC-0258: Outcomes and toxicity of stereotactic body radiotherapy for metastatic and recurrent central lung tumors Radiotherapy and Oncology. 111. DOI: 10.1016/S0167-8140(15)30363-7 |
0.403 |
|
2014 |
Mou B, Merrell KW, Owen DA, Nelson KE, Garces YI, Olivier KR. Stereotactic Body Radiation Therapy for Central Lung Tumors: Outcomes and Toxicity: Treatment Toxicity International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.328 |
0.452 |
|
2014 |
Vu C, Sio T, Chang K, Miller R, Garces Y, Park S, Nelson K, Sloan J, Olivier K. Baseline Patient-Reported Quality of Life Is Not Related to Overall Survival in Patients Receiving Stereotactic Body Radiation Therapy for Thoracic Malignancies: A Preliminary Report International Journal of Radiation Oncology*Biology*Physics. 90: S59. DOI: 10.1016/J.Ijrobp.2014.08.273 |
0.402 |
|
2014 |
Merrell KW, Francis SR, Mou B, Hallemeier CL, Olivier KR. Outcomes and Prognostic Factors of Stereotactic Body Radiation Therapy for Soft-Tissue Sarcoma Metastases International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2216 |
0.391 |
|
2014 |
Park SS, Dong H, Zhao W, Grams MP, Liu X, Harrington SM, Furutani KM, Krco CJ, Olivier KR, Markovic SN, Kwon ED. PD-1 Blockade Enhances Radiation Therapy-Induced Abscopal Effect International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.201 |
0.504 |
|
2014 |
Mou B, Merrell KW, Owen DA, Nelson KE, Garces YI, Olivier KR. Stereotactic Body Radiation Therapy for Central Lung Tumors: Outcomes and Toxicity International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1855 |
0.447 |
|
2014 |
Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Merrell KW, Lee P, Olivier KR, Koong AC, Chang DT. Pooled Analysis of Stereotactic Body Radiation Therapy for Liver Tumors: Results From 5 Institutions International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1223 |
0.396 |
|
2014 |
Owen D, Mayo CS, Song LS, Ahmed K, Laack NN, Olivier KR. Pushing the Dose to the Spinal Cord in Spine SBRT - Cord and Thecal Sac Dosimetric Correlation with Toxicity International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.122 |
0.349 |
|
2014 |
Chang DT, Shaffer J, Pollom E, Stenmark MH, Tang M, Merrell KW, Lee P, Olivier KR, Koong AC, Feng MU. Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Results From a Multi-institution Study International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1211 |
0.413 |
|
2014 |
Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Lee P, Merrell KW, Olivier KR, Koong AC, Chang DT. Pooled Analysis of Liver Stereotactic Body Radiation Therapy for Colorectal Metastases: Results From 5 Institutions International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1210 |
0.417 |
|
2013 |
Grams M, de Los Santos LF, Brown L, Olivier K, Brinkmann D. TH-C-137-04: Separating the Dosimetric Consequences of Changing Tumor Anatomy Vs. Positional Uncertainty for Conventionally Fractionated Lung Cancer Patients. Medical Physics. 40: 533. PMID 28517875 DOI: 10.1118/1.4815747 |
0.355 |
|
2013 |
Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Shon W, García JJ, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. Practical Radiation Oncology. 3: e71-7. PMID 24674323 DOI: 10.1016/J.Prro.2012.06.003 |
0.406 |
|
2013 |
Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). International Journal of Radiation Oncology, Biology, Physics. 87: 73-80. PMID 23920388 DOI: 10.1016/J.Ijrobp.2013.05.012 |
0.563 |
|
2013 |
Stauder MC, Rooney JW, Neben-Wittich MA, Garces YI, Olivier KR. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiation Oncology (London, England). 8: 167. PMID 23829565 DOI: 10.1186/1748-717X-8-167 |
0.427 |
|
2013 |
Seder CW, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Olivier KR, Shen KR, Wigle DA. Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. The Annals of Thoracic Surgery. 95: 1708-16. PMID 23545194 DOI: 10.1016/J.Athoracsur.2013.02.041 |
0.412 |
|
2013 |
Mayo CS, Zankowski C, Herman M, Miller R, Olivier K, Vincent A, Suominen J. A method to vectorize the dose distribution, the dose volume histogram and create a dose vector histogram. Medical Physics. 40: 011717. PMID 23298087 DOI: 10.1118/1.4769111 |
0.304 |
|
2013 |
Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. American Journal of Clinical Oncology. 36: 509-13. PMID 22781389 DOI: 10.1097/Coc.0B013E3182569189 |
0.393 |
|
2013 |
Mayo C, Zankowski C, Herman M, Miller R, Olivier K, Suominen J. SU‐E‐T‐487: A Method to Vectorize the Dose Distribution, the Dose Volume Histogram Medical Physics. 40: 318-318. DOI: 10.1118/1.4814920 |
0.31 |
|
2013 |
Merrell KW, Barney BM, Park SS, Laack NN, Haddock MG, Miller RC, Olivier KR. An Institutional Review of Stereotactic Body Radiation Therapy for Liver Tumors International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.848 |
0.391 |
|
2013 |
Barney B, Callstrom M, Merrell K, Hardie J, Olivier K. Stereotactic Body Radiation Therapy After Other Minimally-Invasive Local Therapies for Liver Tumors International Journal of Radiation Oncology*Biology*Physics. 87: S316. DOI: 10.1016/J.Ijrobp.2013.06.830 |
0.403 |
|
2013 |
Merrell KW, Barney BM, Yan E, Laack NN, Olivier KR. A Comparison of Standard Fractionation and Stereotactic Body Radiation Therapy in the Treatment of Metastatic Breast Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.603 |
0.388 |
|
2013 |
Owen D, Laack N, Mayo C, Garces Y, Park S, Bauer H, Nelson K, Miller R, Brown P, Olivier K. Outcomes and Toxicities of Stereotactic Body Radiation Therapy (SBRT) for Nonspine Osseous Oligometastases International Journal of Radiation Oncology*Biology*Physics. 87: S724. DOI: 10.1016/J.Ijrobp.2013.06.1917 |
0.415 |
|
2013 |
Brown LC, Lester RA, Haddock MG, Sarkaria JN, Olivier KR, Arndt CAS, Laack NN. Stereotactic Body Radiation Therapy (SBRT) for Pediatric Bone Tumors International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.185 |
0.388 |
|
2013 |
Videtic GM, Hu C, Singh A, Chang JY, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H. Radiation Therapy Oncology Group (RTOG) Protocol 0915: A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.016 |
0.361 |
|
2012 |
Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Frontiers in Oncology. 2: 215. PMID 23346551 DOI: 10.3389/Fonc.2012.00215 |
0.417 |
|
2012 |
Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, et al. The clinical case for proton beam therapy. Radiation Oncology (London, England). 7: 174. PMID 23083010 DOI: 10.1186/1748-717X-7-174 |
0.344 |
|
2012 |
Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2919-24. PMID 22782333 DOI: 10.1093/Annonc/Mds123 |
0.402 |
|
2012 |
Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiation Oncology (London, England). 7: 67. PMID 22553982 DOI: 10.1186/1748-717X-7-67 |
0.319 |
|
2012 |
Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. International Journal of Radiation Oncology, Biology, Physics. 82: e803-9. PMID 22330988 DOI: 10.1016/J.Ijrobp.2011.11.036 |
0.437 |
|
2012 |
Barney BM, Olivier KR, Macdonald OK, Fong de Los Santos LE, Miller RC, Haddock MG. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. American Journal of Clinical Oncology. 35: 537-42. PMID 21659830 DOI: 10.1097/Coc.0B013E31821F876A |
0.437 |
|
2012 |
Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 82: 1122-7. PMID 21570217 DOI: 10.1016/J.Ijrobp.2010.09.044 |
0.385 |
|
2012 |
Saito AI, Li JG, Liu C, Olivier KR, Kyougoku S, Dempsey JF. Intravenous contrast agent influence on thoracic computed tomography simulation investigated through a heterogeneous dose calculation method using 5-bulk densities. American Journal of Clinical Oncology. 35: 110-4. PMID 21383608 DOI: 10.1097/Coc.0B013E318209A910 |
0.336 |
|
2012 |
Barney BM, Markovic S, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGF-i) following stereotactic body radiotherapy (SBRT). Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E14507 |
0.499 |
|
2012 |
Ahmed K, Park SS, Kwon ED, Olivier KR. Role of Stereotactic Body Radiation Therapy in Oligometastatic, Hormone Refractory Prostate Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.950 |
0.322 |
|
2012 |
Barney BM, Haddock MG, Miller RC, Olivier KR. Clinical Outcomes and Toxicity Using Stereotactic Body Radiation Therapy (SBRT) for Advanced Cholangiocarcinoma International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.854 |
0.417 |
|
2012 |
Sio T, Jensen A, Fong de los Santos L, Park S, Hallemeier C, Ma D, Bauer H, Olivier K. S-Frame Versus Dual Vacuum: A Comparison of Immobilization Techniques for Upper Lung Tumors With Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 84: S726. DOI: 10.1016/J.Ijrobp.2012.07.1944 |
0.414 |
|
2012 |
Stauder MC, Roden AC, Wigle D, Price KA, Garces YI, Olivier KR. Radiologic Tumor Regression and Correlation With Pathologic Findings After Neoadjuvant Therapy for Non-small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1462 |
0.39 |
|
2012 |
Hallemeier C, Garces Y, Neben-Wittich M, Olivier K, Garcia J, Brown P, Foote R. Adjuvant Hypofractionated Intensity Modulated Radiation Therapy (IMRT) After Resection of Regional Lymph Node (LN) Metastases in Patients With Malignant Melanoma of the Head and Neck International Journal of Radiation Oncology*Biology*Physics. 84: S505-S506. DOI: 10.1016/J.Ijrobp.2012.07.1348 |
0.381 |
|
2011 |
Schild SE, Foster NR, Meyers JP, Olivier KR, Ross HJ, Molina JR, Stella PJ, Past LR, Garces YI, Adjei AA. Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC): Findings from a North Central Cancer Treatment Group (NCCTG) pooled analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7074. PMID 28020366 DOI: 10.1200/Jco.2011.29.15_Suppl.7074 |
0.329 |
|
2011 |
Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 99: 166-71. PMID 21571384 DOI: 10.1016/J.Radonc.2011.04.002 |
0.41 |
|
2011 |
Shi W, Li JG, Zlotecki RA, Yeung A, Newlin H, Palta J, Liu C, Chvetsov AV, Olivier K. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment. American Journal of Clinical Oncology. 34: 16-21. PMID 21189455 DOI: 10.1097/Coc.0B013E3181D26B1A |
0.304 |
|
2011 |
Barney B, Olivier K, Wilson Z, Miller R, Macdonald O, Brown P, Foote R, Markovic S. Clinical Outcomes and Toxicity using Stereotactic Body Radiotherapy (SBRT) for Stage IV Melanoma International Journal of Radiation Oncology*Biology*Physics. 81: S687. DOI: 10.1016/J.Ijrobp.2011.06.959 |
0.511 |
|
2011 |
Stauder M, Olivier K, Macdonald O, Lafata K, Mayo C, Bauer H, Miller R, Brown P, Garces Y. Maximum PTV Dose Predicts for Radiation Pneumonitis Following Lung Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 81: S614. DOI: 10.1016/J.Ijrobp.2011.06.1156 |
0.453 |
|
2010 |
Shi W, Liu C, Lu B, Yeung A, Newlin HE, Amdur RJ, Olivier KR. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. American Journal of Clinical Oncology. 33: 153-6. PMID 19806038 DOI: 10.1097/Coc.0B013E3181A44637 |
0.43 |
|
2010 |
Wickham T, Reynolds J, Drummond D, Kirpotin D, Lahdenranta J, Leonard S, Geretti E, Lee H, Klinz S, Hendriks B, Olivier K, Eckelhofer I, Park J, Benz C, Moyo V, et al. Abstract P3-14-09: Preclinical Safety and Activity of MM-302, a HER2-Targeted Liposomal Doxorubicin Designed To Have an Improved Safety and Efficacy Profile over Approved Anthracyclines Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-14-09 |
0.315 |
|
2010 |
Stauder M, MacDonald O, Olivier K, Miller R, Brown P, Garces Y. Early Pulmonary Toxicity of Lung Stereotactic Body Radiation Therapy (SBRT) Delivered as Consecutive Daily Fractions International Journal of Radiation Oncology*Biology*Physics. 78: S182-S183. DOI: 10.1016/J.Ijrobp.2010.07.444 |
0.418 |
|
2010 |
Woltman NM, Garces Y, Olivier K, Miller R. Incidence of Radiation Pneumonitis after Thoracic Intensity Modulated Radiation Therapy International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.1709 |
0.392 |
|
2009 |
Amdur RJ, Bennett J, Olivier K, Wallace A, Morris CG, Liu C, Mendenhall WM. A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. American Journal of Clinical Oncology. 32: 515-20. PMID 19528790 DOI: 10.1097/Coc.0B013E318194F70F |
0.355 |
|
2009 |
Saito AI, Li JG, Liu C, Olivier KR, Dempsey JF. Accurate heterogeneous dose calculation for lung cancer patients without high-resolution CT densities. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 10: 2847. PMID 19458588 DOI: 10.1120/Jacmp.V10I2.2847 |
0.356 |
|
2009 |
Chang DT, Mendenhall NP, Lynch JW, Morris CG, Olivier KR. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. American Journal of Clinical Oncology. 32: 233-7. PMID 19433961 DOI: 10.1097/Coc.0B013E318187Ddbb |
0.349 |
|
2009 |
Yeung AR, Li JG, Shi W, Newlin HE, Chvetsov A, Liu C, Palta JR, Olivier K. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. International Journal of Radiation Oncology, Biology, Physics. 74: 1100-7. PMID 19395197 DOI: 10.1016/J.Ijrobp.2008.09.048 |
0.377 |
|
2009 |
Newlin HE, Iyengar M, Morris CG, Olivier K. Unresectable Squamous Cell Carcinoma of the Lung: An Outcomes Study International Journal of Radiation Oncology Biology Physics. 74: 370-376. PMID 19356860 DOI: 10.1016/J.Ijrobp.2008.08.019 |
0.417 |
|
2009 |
Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. American Journal of Clinical Oncology. 32: 180-6. PMID 19307953 DOI: 10.1097/Coc.0B013E3181841F13 |
0.326 |
|
2009 |
Chang DT, Amdur RJ, Pacholke H, Mendenhall NP, Morris CG, Byer GA, Olivier KR. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques? American Journal of Clinical Oncology. 32: 145-9. PMID 19307951 DOI: 10.1097/Coc.0B013E3181841F42 |
0.349 |
|
2009 |
Macdonald O, Kazemba B, Olivier K, Brown P, Miller R, Fong de Los Santos L, Garces Y. Comparative Analysis of Coplanar vs. Noncoplanar Planning Approaches in Extra-cranial Stereotactic Radiotherapy (SBRT) of Early Stage Peripheral Non-Small Cell Lung Cancer (NSCLC) International Journal of Radiation Oncology*Biology*Physics. 75: S686-S687. DOI: 10.1016/J.Ijrobp.2009.07.1566 |
0.358 |
|
2008 |
Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. International Journal of Radiation Oncology, Biology, Physics. 72: 1426-33. PMID 18762391 DOI: 10.1016/J.Ijrobp.2008.03.031 |
0.34 |
|
2008 |
Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 70: 744-51. PMID 17904306 DOI: 10.1016/J.Ijrobp.2007.07.2335 |
0.394 |
|
2008 |
Yeung A, Li J, Shi W, Newlin H, Chvetsov A, Liu C, Palta J, Olivier K. Tumor Localization using Cone-beam Computed Tomography Reduces Setup Margin in Conventionally Fractionated Radiotherapy for Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 72: S446. DOI: 10.1016/J.Ijrobp.2008.06.1825 |
0.342 |
|
2008 |
Olivier K, Li J, Shi W, Newlin H, Chvetsov A, Liu C, Palta J, Yeung A. Optimal Frequency of Image Guidance with Cone-beam Computed Tomography in Conventionally Fractionated Radiotherapy for Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 72: S439-S440. DOI: 10.1016/J.Ijrobp.2008.06.1811 |
0.32 |
|
2008 |
Newlin H, Chvetsov A, Rutenberg M, Olivier K. Serial Kilovoltage Cone-beam Computed Tomography Imaging during Intensity Modulated Radiotherapy for Primary Lung Cancers: Observations of Treatment Effect and Tumor-volume Regression International Journal of Radiation Oncology*Biology*Physics. 72: S431. DOI: 10.1016/J.Ijrobp.2008.06.1354 |
0.371 |
|
2007 |
Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. American Journal of Clinical Oncology. 30: 601-606. PMID 18091054 DOI: 10.1097/Coc.0B013E318145B9Db |
0.371 |
|
2007 |
Olivier KR, Schild SE, Morris CG, Brown PO, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma Cancer. 110: 1791-1795. PMID 17721993 DOI: 10.1002/Cncr.22988 |
0.535 |
|
2007 |
Chang D, Liu C, Dempsey JF, Palta JR, Kopea J, Louis D, Morris C, Chopra R, Olivier KR. Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. American Journal of Clinical Oncology. 30: 57-62. PMID 17278896 DOI: 10.1097/01.Coc.0000251222.36417.3B |
0.367 |
|
2007 |
Ani SA, Song W, Ozawa S, Amdur R, Olivier K, Liu C, Li J. Evaluation of Intra-Fractional Patient Movement During Image Guided Stereotactic Body Radiation Therapy of Spine and Lung Patients International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.2036 |
0.428 |
|
2007 |
Saito AI, Li JG, Liu C, Olivier KR, Dempsey JF. Lung Tumor Intra-Fraction Motion During Stereotactic Body Radiotherapy (SBRT): An Evaluation Using Ciné MR International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1722 |
0.357 |
|
2007 |
Newlin HE, Iyengar M, Morris CG, Olivier KR. The Effect of Dose and Fractionation on Squamous Cell Carcinoma of the Lung International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.1708 |
0.33 |
|
2007 |
Olivier K, Vargas C, Louis D, Chang D, Newlin H, Liu C. Comparison of Prescription Methods for Stereotactic Body Radiotherapy in Lung Cancer International Journal of Radiation Oncology Biology Physics. 69. DOI: 10.1016/J.Ijrobp.2007.07.158 |
0.357 |
|
2006 |
Liauw SL, Yeh AM, Morris CG, Olivier KR, Mendenhall NP. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. International Journal of Radiation Oncology, Biology, Physics. 66: 1440-5. PMID 16997504 DOI: 10.1016/J.Ijrobp.2006.07.014 |
0.301 |
|
2006 |
Chang DT, Olivier KR, Morris CG, Liu C, Dempsey JF, Benda RK, Palta JR. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. International Journal of Radiation Oncology, Biology, Physics. 65: 125-31. PMID 16427214 DOI: 10.1016/J.Ijrobp.2005.09.047 |
0.367 |
|
2006 |
Olivier K, Chung H, Jin H, Yang H, Kim S. 2501 : Intra-Fraction Patient Displacement During Image-Guided Stereotactic Body Radiation Therapy (IGSBRT) for Lung Treatment International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.913 |
0.445 |
|
2006 |
Saito AI, Li JG, Liu C, Olivier KR, Dempsey JF. 2831 : Accurate Heterogeneous Dose Calculation for Lung Cancer Patients Without High Resolution CT Densities International Journal of Radiation Oncology Biology Physics. 66. DOI: 10.1016/J.Ijrobp.2006.07.1249 |
0.355 |
|
2005 |
Chang DT, Zlotecki RA, Olivier KR. Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. American Journal of Clinical Oncology. 28: 597-602. PMID 16317271 DOI: 10.1097/01.Coc.0000187927.06051.Ec |
0.41 |
|
2005 |
Olivier KR, Brown PD, Stafford SL, Ansell SM, Martenson JA. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. International Journal of Radiation Oncology, Biology, Physics. 60: 1510-4. PMID 15590182 DOI: 10.1016/J.Ijrobp.2004.05.066 |
0.329 |
|
2004 |
Olivier KR, Stafford SL. Radiotherapy for MALT lymphoma. Mayo Clinic Proceedings. 79: 276; author reply 27. PMID 14959927 DOI: 10.4065/79.2.276 |
0.337 |
|
2002 |
Olivier KR, Brown PD, Stafford SL, Ansell SM, Martenson JA. Efficacy of Radiotherapy for Primary NHL of the Parotid The Cancer Journal. 8: 491. DOI: 10.1097/00130404-200211000-00034 |
0.352 |
|
Show low-probability matches. |